Myelodysplastic subclones in chronic myeloid leukemia: implications for imatinib mesylate therapy.
Goldberg
Stuart L
SL
Madan
Ravi A
RA
Rowley
Scott D
SD
Pecora
Andrew L
AL
Hsu
Jack W
JW
Tantravahi
Ramana
R
D001549:Benzamides; D019070:Cell Lineage; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D002999:Clone Cells / Q000473:pathology; D020732:Cytogenetic Analysis; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D025202:Molecular Diagnostic Techniques; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate